微环境和分子途径驱动休眠逃逸在骨转移中
Mohamad Bakir1, Alhomam Dabaliz2, Ahmad Dawalibi3
1Department of Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
International journal of molecular sciences
|December 30, 2025
概括
骨中传播的瘤细胞 (DTC) 可以保持多年的休眠状态. 这篇评论探讨了骨微环境如何触发DTCs重新唤醒,导致癌症复发,并讨论了防止这种逃逸的潜在疗法.
科学领域:
- 在瘤学瘤学.
- 癌症转移 癌症转移
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨转移是晚期癌症的主要死亡原因.
- 散布的瘤细胞 (DTC) 可以进入骨的休眠状态,导致晚期复发.
- 休眠逃脱的机制尚不清楚,但对于预防转移至关重要.
研究的目的:
- 审查有关骨微环境如何促进DTCs的休眠逃脱的新兴证据.
- 讨论骨内促进瘤细胞重新激活的因素.
- 为了评估针对休眠逃脱的治疗策略.
主要方法:
- 文献综述综合了有关骨转移休眠和重新激活的当前研究.
- 对影响瘤细胞持久性和脱离的分子,细胞和系统因素的分析.
- 评估治疗干预措施,以管理休眠骨转移.
主要成果:
- 骨质再吸收释放生长因子 (例如TGF-β,IGF-1),这些生长因子可促进骨质再激活.
- 骨质细胞介导静止和脂肪细胞支持的破坏促进了增殖.
- 免疫抑制,ECM重塑和系统因素有助于休眠逃脱.
- 表观遗传和代谢重编程可以使瘤细胞重新激活.
结论:
- 骨微环境通过各种线索积极协调休眠逃脱.
- 准骨质细胞活动,免疫抑制和代谢途径可以预防复发.
- 需要进一步的研究来确定关键的知识差距,并制定有效的干预措施.
相关概念视频
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K


